Effect of a combined oral contraceptive containing 20 μg ethinyl estradiol and 75 μg gestodene on hemostatic parameters

JM Aldrighi, LS Carneiro De Campos… - Gynecological …, 2006 - Taylor & Francis
The effects of a combined oral contraceptive (COC) containing 20 μg ethinyl estradiol (EE)
and 75 μg gestodene (GSD) on prothrombin activity (PA), activated partial thromboplastin …

Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian …

AC Ferreira, MB Montes, SA Franceschini… - International journal of …, 2001 - europepmc.org
Objective Blood coagulation and fibrinolytic variables were evaluated in 46 Brazilian women
treated with either of two monophasic oral contraceptives (OC), containing 30 or 20 microg …

Effects of two combined monophasic and triphasic ethinylestradiol/gestodene oral contraceptives on natural inhibitors and other hemostatic variables

G Creatsas, I Kontopoulou-Griva… - … European Journal of …, 1997 - Taylor & Francis
Objective To evaluate the effects of two preparations of combined oral contraceptives
(COCs), the monophasic COC containing 30 μg ethinylestradiol and 75 μg gestodene and …

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol

UH Winkler, AE Schindler, J Endrikat, B Düsterberg - Contraception, 1996 - Elsevier
The effects of two oral contraceptives, containing gestodene and either 20 μg or 30 μg
ethinylestradiol, on hemostatic parameters was investigated in a six-month randomized …

Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters

J Douxfils, C Klipping, I Duijkers, V Kinet, M Mawet… - Contraception, 2020 - Elsevier
Objective To assess the effect on hemostasis parameters of a new combined oral
contraceptive (COC). Study design In this randomized, single centre, open-label, exploratory …

A comparative study on the effects of a monophasic pill containing desogestrel plus 20 μg ethinylestradiol, a triphasic combination containing levonorgestrel and a …

GB Melis, F Fruzzetti, I Nicoletti, C Ricci, P Lammers… - Contraception, 1991 - Elsevier
The changes in haemostasis during oral contraception are related to the ethinylestradiol
dose present in the formulation taken by the patient. An open, randomized longitudinal study …

Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel

RNV Prasad, SCL Koh, OAC Viegas… - Clinical and Applied …, 1999 - journals.sagepub.com
We studied 67 healthy women who were randomly allocated to receive third generation
gestodene (Gynera®) or second generation levonorgestrel (Microgynon 30®) combina tion …

Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters

I Wiegratz, S Stahlberg, T Manthey, N Sänger… - Contraception, 2008 - Elsevier
BACKGROUND: The study was conducted to investigate the effect of a combined oral
contraceptive (COC) containing 30 mcg ethinylestradiol and 2 mg dienogest with two …

Hemostatic effects of two oral contraceptives containing low doses of ethinyl estradiol and either gestodene or norgestimate: an open, randomized, parallel-group …

UH Winkler, C Oberhoff, U Bier… - … journal of fertility and …, 1995 - europepmc.org
Results Both formulations increased coagulatory as well as fibrinolytic activity over baseline:
circulating reactive products of thrombin increased by 40%, and plasmin activity by 60 …

The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study

TO Contraceptive, Hemostasis Study Group - Contraception, 2003 - Elsevier
We investigated the effects of ethinylestradiol dose (50, 30 and 20 μg) and progestogen type
[desogestrel (DSG), gestodene (GSD), levonorgestrel (LNG) and norgestimate (NGM)] in …